Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) FCF Margin (2017 - 2025)

Selectis Health's FCF Margin history spans 14 years, with the latest figure at 6.07% for Q4 2025.

  • Quarterly results put FCF Margin at 6.07% for Q4 2025, up 1024.0% from a year ago — trailing twelve months through Dec 2025 was 3.47% (up 818.0% YoY), and the annual figure for FY2025 was 3.47%, up 818.0%.
  • FCF Margin for Q4 2025 was 6.07% at Selectis Health, up from 2.54% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 26.23% in Q3 2023 to a low of 20.17% in Q4 2023.
  • The 5-year median for FCF Margin is 1.72% (2023), against an average of 1.27%.
  • The sharpest move saw FCF Margin soared 3658bps in 2023, then plummeted -3848bps in 2024.
  • Year by year, FCF Margin stood at 12.83% in 2021, then plummeted by -67bps to 4.2% in 2022, then tumbled by -580bps to 20.17% in 2023, then skyrocketed by 79bps to 4.17% in 2024, then surged by 246bps to 6.07% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 6.07%, 2.54%, and 2.31% for Q4 2025, Q3 2025, and Q2 2025 respectively.